chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: F
Vaccine: COVID19
Symptoms: Rhinorrhoea
Clinical narrative: runny nose; This spontaneous case was reported by a consumer and describes the occurrence of RHINORRHOEA (runny nose) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Mar-2021, the patient experienced RHINORRHOEA (runny nose). At the time of the report, RHINORRHOEA (runny nose) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications reported.  Treatment medications was not provided by the reporter
Age: 84.0
Sex: F
Vaccine: COVID19
Symptoms: Peripheral swelling
Clinical narrative: Swollen legs; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of PERIPHERAL SWELLING (Swollen legs) in an 84-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 03M20A) for COVID-19 vaccination.     No reported medical history.  Concomitant products included FAMOTIDINE and LEVOTHYROXINE SODIUM (SYNTHROID) for an unknown indication.    On 30-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 31-Jan-2021, the patient experienced PERIPHERAL SWELLING (Swollen legs). At the time of the report, PERIPHERAL SWELLING (Swollen legs) had not resolved.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.       The patient's doctor prescribed a water pill that help a little with her edema.   This case was linked to MOD-2021-032407 (Patient Link).
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Device connection issue, Underdose
Clinical narrative: Underdose; syringe was not secured enough; This spontaneous case was reported by a nurse and describes the occurrence of UNDERDOSE (Underdose) and DEVICE CONNECTION ISSUE (syringe was not secured enough) in a 45-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002A21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (Medical history was not reported).   On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form.   On 02-Mar-2021, the patient experienced UNDERDOSE (Underdose) and DEVICE CONNECTION ISSUE (syringe was not secured enough). On 02-Mar-2021, UNDERDOSE (Underdose) and DEVICE CONNECTION ISSUE (syringe was not secured enough) had resolved.      For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter. No treatment information was provided.
Age: 85.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus
Clinical narrative: Itch back, hip and arm (both); This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (Itch back, hip and arm (both)) in an 85-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 001A21A and 004M20A) for COVID-19 vaccination.     Concurrent medical conditions included Arthritis. Concomitant products included MULTIVITAMIN [VITAMINS NOS] for an unknown indication.   On 30-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PRURITUS (Itch back, hip and arm (both)). At the time of the report, PRURITUS (Itch back, hip and arm (both)) outcome was unknown.            Treatment medications was not provided by the reporter
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia, Vaccination site pain
Clinical narrative: Muscle pain; Tenderness (injection site); This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (Muscle pain) and VACCINATION SITE PAIN (Tenderness (injection site)) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031M20A) for COVID-19 vaccination.     The patient's past medical history included COVID-19 in November 2020.    On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced MYALGIA (Muscle pain) and VACCINATION SITE PAIN (Tenderness (injection site)). At the time of the report, MYALGIA (Muscle pain) and VACCINATION SITE PAIN (Tenderness (injection site)) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported.  No treatment information was provided.   This case was linked to MOD-2021-031843.
Age: 62.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Back pain, Headache, Neuralgia, Pain in extremity
Clinical narrative: Blurry vision / Cannot focus completely; Back pain; Pain from wrist all the way up to his forearm; Nicked the nerve while taking the shot; Feels like his vision is not right; Little swollen arm; Arm is red; Sore arm; Carpel tunnel pain /  joint soreness; Headache; This spontaneous case was reported by a consumer and describes the occurrence of VISION BLURRED (Blurry vision / Cannot focus completely), BACK PAIN (Back pain), PAIN IN EXTREMITY (Pain from wrist all the way up to his forearm), NEURALGIA (Nicked the nerve while taking the shot) and VISUAL IMPAIRMENT (Feels like his vision is not right) in a 62-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 022M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No reported medical history.  Concomitant products included ROSUVASTATIN, FINASTERIDE and AZILSARTAN MEDOXOMIL, CHLORTALIDONE (EDARBYCLOR) for an unknown indication.    On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Feb-2021, the patient experienced VISION BLURRED (Blurry vision / Cannot focus completely), BACK PAIN (Back pain), PAIN IN EXTREMITY (Pain from wrist all the way up to his forearm), NEURALGIA (Nicked the nerve while taking the shot), VISUAL IMPAIRMENT (Feels like his vision is not right), VACCINATION SITE SWELLING (Little swollen arm), VACCINATION SITE ERYTHEMA (Arm is red), VACCINATION SITE PAIN (Sore arm), ARTHRALGIA (Carpel tunnel pain /  joint soreness) and HEADACHE (Headache). The patient was treated with PARACETAMOL (TYLENOL) for Adverse event NOS, at an unspecified dose and frequency. At the time of the report, VISION BLURRED (Blurry vision / Cannot focus completely), BACK PAIN (Back pain), PAIN IN EXTREMITY (Pain from wrist all the way up to his forearm), NEURALGIA (Nicked the nerve while taking the shot), VISUAL IMPAIRMENT (Feels like his vision is not right), VACCINATION SITE SWELLING (Little swollen arm), VACCINATION SITE ERYTHEMA (Arm is red), VACCINATION SITE PAIN (Sore arm), ARTHRALGIA (Carpel tunnel pain /  joint soreness) and HEADACHE (Headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Age: 62.0
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pain, Vaccination site swelling, Vision blurred, Visual impairment
Clinical narrative: Blurry vision / Cannot focus completely; Back pain; Pain from wrist all the way up to his forearm; Nicked the nerve while taking the shot; Feels like his vision is not right; Little swollen arm; Arm is red; Sore arm; Carpel tunnel pain /  joint soreness; Headache; This spontaneous case was reported by a consumer and describes the occurrence of VISION BLURRED (Blurry vision / Cannot focus completely), BACK PAIN (Back pain), PAIN IN EXTREMITY (Pain from wrist all the way up to his forearm), NEURALGIA (Nicked the nerve while taking the shot) and VISUAL IMPAIRMENT (Feels like his vision is not right) in a 62-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 022M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No reported medical history.  Concomitant products included ROSUVASTATIN, FINASTERIDE and AZILSARTAN MEDOXOMIL, CHLORTALIDONE (EDARBYCLOR) for an unknown indication.    On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Feb-2021, the patient experienced VISION BLURRED (Blurry vision / Cannot focus completely), BACK PAIN (Back pain), PAIN IN EXTREMITY (Pain from wrist all the way up to his forearm), NEURALGIA (Nicked the nerve while taking the shot), VISUAL IMPAIRMENT (Feels like his vision is not right), VACCINATION SITE SWELLING (Little swollen arm), VACCINATION SITE ERYTHEMA (Arm is red), VACCINATION SITE PAIN (Sore arm), ARTHRALGIA (Carpel tunnel pain /  joint soreness) and HEADACHE (Headache). The patient was treated with PARACETAMOL (TYLENOL) for Adverse event NOS, at an unspecified dose and frequency. At the time of the report, VISION BLURRED (Blurry vision / Cannot focus completely), BACK PAIN (Back pain), PAIN IN EXTREMITY (Pain from wrist all the way up to his forearm), NEURALGIA (Nicked the nerve while taking the shot), VISUAL IMPAIRMENT (Feels like his vision is not right), VACCINATION SITE SWELLING (Little swollen arm), VACCINATION SITE ERYTHEMA (Arm is red), VACCINATION SITE PAIN (Sore arm), ARTHRALGIA (Carpel tunnel pain /  joint soreness) and HEADACHE (Headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Age: 30.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Myalgia
Clinical narrative: Body aches; Chills; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (Body aches) and CHILLS (Chills) in a 30-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012M20A) for COVID-19 vaccination.     Concurrent medical conditions included ADD. Concomitant products included BAMLANIVIMAB from 14-Jan-2021 to an unknown date for an unknown indication.    On 24-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Feb-2021, the patient experienced MYALGIA (Body aches) and CHILLS (Chills). The patient was treated with PARACETAMOL (TYLENOL) for Adverse reaction, at a dose of 1 dosage form. On 24-Feb-2021, CHILLS (Chills) had resolved. On 25-Feb-2021, MYALGIA (Body aches) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient's concomitant medications included unspecified medicine for ADD.
Sex: F
Vaccine: COVID19
Symptoms: COVID-19
Clinical narrative: Developed COVID shortly after the vaccine; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (Developed COVID shortly after the vaccine) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) at an unspecified dose. On an unknown date, the patient experienced COVID-19 (Developed COVID shortly after the vaccine). At the time of the report, COVID-19 (Developed COVID shortly after the vaccine) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported.  No treatment information was provided.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Ear pain, Hyperaesthesia teeth, Toothache
Clinical narrative: Pain in one of her teeth / Teeth pain; The root of the upper tooth on the right side of her mouth was very sensitive / the root of the teeth are sensitive/ sensitive to hot / bottom right was sensitive to hot and cold; Earache that comes and goes; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of TOOTHACHE (Pain in one of her teeth / Teeth pain), HYPERAESTHESIA TEETH (The root of the upper tooth on the right side of her mouth was very sensitive / the root of the teeth are sensitive/ sensitive to hot / bottom right was sensitive to hot and cold) and EAR PAIN (Earache that comes and goes) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 010MZ0A and 006MZ0A) for COVID-19 vaccination.     Concomitant products included ATORVASTATIN CALCIUM (LIPITOR), LISINOPRIL, HCTZ, FLUTICASONE FUROATE, VILANTEROL TRIFENATATE (BREO ELLIPTA), AMLODIPINE, LEVOTHYROXINE, OMEPRAZOLE (PROTONIX [OMEPRAZOLE]) and VITAMIN D NOS for an unknown indication.   On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced TOOTHACHE (Pain in one of her teeth / Teeth pain), HYPERAESTHESIA TEETH (The root of the upper tooth on the right side of her mouth was very sensitive / the root of the teeth are sensitive/ sensitive to hot / bottom right was sensitive to hot and cold) and EAR PAIN (Earache that comes and goes). The patient was treated with PARACETAMOL (TYLENOL) for Adverse event NOS, at an unspecified dose and frequency and IBUPROFEN for Adverse event NOS, at an unspecified dose and frequency. At the time of the report, TOOTHACHE (Pain in one of her teeth / Teeth pain), HYPERAESTHESIA TEETH (The root of the upper tooth on the right side of her mouth was very sensitive / the root of the teeth are sensitive/ sensitive to hot / bottom right was sensitive to hot and cold) and EAR PAIN (Earache that comes and goes) outcome was unknown.            The patient did not experience any side effects with the first dose.
Age: 33.0
Sex: M
Vaccine: COVID19
Symptoms: Dizziness, Fatigue, Feeling hot, Pain in extremity, Vaccination site mass
Clinical narrative: sore arm; tiny bump at injection site; dizziness; feels warm; fatigue; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm), VACCINATION SITE MASS (tiny bump at injection site), DIZZINESS (dizziness), FEELING HOT (feels warm) and FATIGUE (fatigue) in a 33-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (sore arm), VACCINATION SITE MASS (tiny bump at injection site), DIZZINESS (dizziness), FEELING HOT (feels warm) and FATIGUE (fatigue). At the time of the report, PAIN IN EXTREMITY (sore arm), VACCINATION SITE MASS (tiny bump at injection site), DIZZINESS (dizziness), FEELING HOT (feels warm) and FATIGUE (fatigue) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported. Treatment medications were not provided by the reporter   Most recent FOLLOW-UP information incorporated above includes: On 20-Jul-2021: Non significant follow up appended On 21-Jul-2021: NNI,Patient declined for follow up
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Dysgeusia, Hypoaesthesia, Hypoaesthesia oral, Paraesthesia
Clinical narrative: Metallic taste in mouth; Numbness below ear; Right tongue went numb; Right cheek was tingling / Tingly sensation similar to shingles; This spontaneous case was reported by a consumer and describes the occurrence of DYSGEUSIA (Metallic taste in mouth), HYPOAESTHESIA (Numbness below ear), HYPOAESTHESIA ORAL (Right tongue went numb) and PARAESTHESIA (Right cheek was tingling / Tingly sensation similar to shingles) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025a21a) for COVID-19 vaccination.     Previously administered products included for an unreported indication: VARICELLA ZOSTER VACCINE. Past adverse reactions to the above products included Tingling sensation with VARICELLA ZOSTER VACCINE. Concomitant products included ASPIRIN [ACETYLSALICYLIC ACID] for an unknown indication.    On 28-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Feb-2021, the patient experienced DYSGEUSIA (Metallic taste in mouth), HYPOAESTHESIA (Numbness below ear), HYPOAESTHESIA ORAL (Right tongue went numb) and PARAESTHESIA (Right cheek was tingling / Tingly sensation similar to shingles). At the time of the report, DYSGEUSIA (Metallic taste in mouth), HYPOAESTHESIA (Numbness below ear), HYPOAESTHESIA ORAL (Right tongue went numb) and PARAESTHESIA (Right cheek was tingling / Tingly sensation similar to shingles) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was provided.
Age: 82.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site warmth
Clinical narrative: Warm to the touch; Big Red Spot on Injection Site (The Size of a Large Orange); This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (Warm to the touch) and VACCINATION SITE ERYTHEMA (Big Red Spot on Injection Site (The Size of a Large Orange)) in an 82-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 024M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 15-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Feb-2021, the patient experienced VACCINATION SITE WARMTH (Warm to the touch) and VACCINATION SITE ERYTHEMA (Big Red Spot on Injection Site (The Size of a Large Orange)). At the time of the report, VACCINATION SITE WARMTH (Warm to the touch) and VACCINATION SITE ERYTHEMA (Big Red Spot on Injection Site (The Size of a Large Orange)) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported.  No treatment information was provided.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Headache
Clinical narrative: Little dizziness; Headache; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Little dizziness) and HEADACHE (Headache) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014M20A) for COVID-19 vaccination.     Concurrent medical conditions included Blood pressure abnormal.    On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In March 2021, the patient experienced DIZZINESS (Little dizziness) and HEADACHE (Headache). The patient was treated with PARACETAMOL (TYLENOL) ongoing from 01-Mar-2021 at a dose of unknown. At the time of the report, DIZZINESS (Little dizziness) and HEADACHE (Headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient's concomitant medications included unspecified medicine for blood pressure and other unspecified medications.   Reporter did not allow further contact
Age: 84.0
Sex: F
Vaccine: COVID19
Symptoms: Chills
Clinical narrative: Chills; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of CHILLS (Chills) in an 84-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 03M20A??) for COVID-19 vaccination.     No reported medical history. .  Concomitant products included FAMOTIDINE and LEVOTHYROXINE SODIUM (SYNTHROID) for an unknown indication.   On 30-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 28-Feb-2021, the patient experienced CHILLS (Chills). At the time of the report, CHILLS (Chills) had not resolved.            No treatment information was provided.   This case was linked to MOD-2021-032389 (Patient Link).
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Product dose omission issue
Clinical narrative: Patient overdue for 2nd dose of vaccine; A spontaneous report  was received from a consumer, who was a 69-year-old, female patient, who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced patient overdue for 2nd dose of vaccine.  The patient's medical history was not provided. No concomitant product use was reported.  On 13-Jan-2021, the patient received their first of two planned doses of mRNA-1273 (Lot number: not provided) intramuscularly on left arm for prophylaxis of COVID-19 infection. The patient reported that she was overdue to receive her second dose of the two planned doses and it had been past 42 days.  Action taken with mRNA-1273 was unknown.  The outcome of the event patient overdue for 2nd dose of vaccine was considered resolved.; Reporter's Comments: Based on reporter's causality and nothing refers to the product being administered due to a "missed dose" the event is assessed as unlikely related to mRNA-1273.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Herpes zoster, Pain, Pruritus, Rash
Clinical narrative: Shingles; Rash on the lower abdomen that then extended to the back and itches; Sensitive pains; Rash on the lower abdomen that then extended to the back; This spontaneous case was reported by a consumer and describes the occurrence of HERPES ZOSTER (Shingles), PRURITUS (Rash on the lower abdomen that then extended to the back and itches), PAIN (Sensitive pains) and RASH (Rash on the lower abdomen that then extended to the back) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 24-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Mar-2021, the patient experienced HERPES ZOSTER (Shingles), PRURITUS (Rash on the lower abdomen that then extended to the back and itches), PAIN (Sensitive pains) and RASH (Rash on the lower abdomen that then extended to the back). At the time of the report, HERPES ZOSTER (Shingles), PRURITUS (Rash on the lower abdomen that then extended to the back and itches), PAIN (Sensitive pains) and RASH (Rash on the lower abdomen that then extended to the back) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product details was not provided by the reporter. Treatment information was not provided.   This case was linked to MOD-2021-261735 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 20-Jul-2021: Added reporter's email id and address
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Muscle twitching
Clinical narrative: dizziness to a point where she had to lay down; muscle between her elbow and wrist started "pulsing or jumping up and down" for 2-3 minutes; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (dizziness to a point where she had to lay down) and MUSCLE TWITCHING (muscle between her elbow and wrist started "pulsing or jumping up and down" for 2-3 minutes) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Lyme disease (Patient had reaction like muscle twitches from Lyme disease) since an unknown date.    On 01-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Feb-2021, the patient experienced DIZZINESS (dizziness to a point where she had to lay down) and MUSCLE TWITCHING (muscle between her elbow and wrist started "pulsing or jumping up and down" for 2-3 minutes). At the time of the report, DIZZINESS (dizziness to a point where she had to lay down) and MUSCLE TWITCHING (muscle between her elbow and wrist started "pulsing or jumping up and down" for 2-3 minutes) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided by the reporter. No treatment information was provided.   Most recent FOLLOW-UP information incorporated above includes: On 24-Jun-2021: Follow-up received on 24-jun-2021 , contains no new information
Age: 75.0
Sex: U
Vaccine: COVID19
Symptoms: Vaccination site pain, Vaccination site pruritus
Clinical narrative: Some itching; Second shot was more painful; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (Some itching) and VACCINATION SITE PAIN (Second shot was more painful) in a 75-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 022M20A and 013L20A) for COVID-19 vaccination.     The patient's past medical history included Bypass surgery in May 2020.   On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 24-Feb-2021, the patient experienced VACCINATION SITE PRURITUS (Some itching) and VACCINATION SITE PAIN (Second shot was more painful). On 26-Feb-2021, VACCINATION SITE PAIN (Second shot was more painful) had resolved. On 27-Feb-2021, VACCINATION SITE PRURITUS (Some itching) had resolved.            No relevant concomitant medications were reported.  No treatment information was provided.   This case was linked to MOD-2021-059885 (Patient Link).
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Chills, Hypertension, Myalgia, Pain in extremity
Clinical narrative: her legs were loose; feet tingling; Itching; leg pain; High blood pressure; like a chills wave from her feet upwards; body pain; injection site pain for 2 days; This spontaneous case was reported by a consumer and describes the occurrence of ASTHENIA (her legs were loose), PARAESTHESIA (feet tingling), PRURITUS (Itching), PAIN IN EXTREMITY (leg pain) and HYPERTENSION (High blood pressure) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No reported medical history.  Concomitant products included LEVOTHYROXINE, PRAVASTATIN, ALENDRONATE SODIUM (ALENDRONATE), TAMSULOSIN, METHENAMINE HIPPURATE, VITAMIN D3, VITAMIN B12 [VITAMIN B12 NOS], VITAMIN C [ASCORBIC ACID], MULTIVITAMIN [VITAMINS NOS] and PROBIOTICS NOS for an unknown indication.    On 25-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Feb-2021, the patient experienced VACCINATION SITE PAIN (injection site pain for 2 days). On 27-Feb-2021, the patient experienced ASTHENIA (her legs were loose), PARAESTHESIA (feet tingling), PRURITUS (Itching), PAIN IN EXTREMITY (leg pain), HYPERTENSION (High blood pressure), CHILLS (like a chills wave from her feet upwards) and MYALGIA (body pain). The patient was treated with PARACETAMOL (TYLENOL) for Adverse event NOS, at an unspecified dose and frequency and DESLORATADINE for Adverse event NOS, at an unspecified dose and frequency. On 27-Feb-2021, VACCINATION SITE PAIN (injection site pain for 2 days) had resolved. At the time of the report, ASTHENIA (her legs were loose), PARAESTHESIA (feet tingling), PRURITUS (Itching), PAIN IN EXTREMITY (leg pain), HYPERTENSION (High blood pressure), CHILLS (like a chills wave from her feet upwards) and MYALGIA (body pain) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Paraesthesia, Pruritus, Vaccination site pain
Clinical narrative: her legs were loose; feet tingling; Itching; leg pain; High blood pressure; like a chills wave from her feet upwards; body pain; injection site pain for 2 days; This spontaneous case was reported by a consumer and describes the occurrence of ASTHENIA (her legs were loose), PARAESTHESIA (feet tingling), PRURITUS (Itching), PAIN IN EXTREMITY (leg pain) and HYPERTENSION (High blood pressure) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No reported medical history.  Concomitant products included LEVOTHYROXINE, PRAVASTATIN, ALENDRONATE SODIUM (ALENDRONATE), TAMSULOSIN, METHENAMINE HIPPURATE, VITAMIN D3, VITAMIN B12 [VITAMIN B12 NOS], VITAMIN C [ASCORBIC ACID], MULTIVITAMIN [VITAMINS NOS] and PROBIOTICS NOS for an unknown indication.    On 25-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Feb-2021, the patient experienced VACCINATION SITE PAIN (injection site pain for 2 days). On 27-Feb-2021, the patient experienced ASTHENIA (her legs were loose), PARAESTHESIA (feet tingling), PRURITUS (Itching), PAIN IN EXTREMITY (leg pain), HYPERTENSION (High blood pressure), CHILLS (like a chills wave from her feet upwards) and MYALGIA (body pain). The patient was treated with PARACETAMOL (TYLENOL) for Adverse event NOS, at an unspecified dose and frequency and DESLORATADINE for Adverse event NOS, at an unspecified dose and frequency. On 27-Feb-2021, VACCINATION SITE PAIN (injection site pain for 2 days) had resolved. At the time of the report, ASTHENIA (her legs were loose), PARAESTHESIA (feet tingling), PRURITUS (Itching), PAIN IN EXTREMITY (leg pain), HYPERTENSION (High blood pressure), CHILLS (like a chills wave from her feet upwards) and MYALGIA (body pain) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Dizziness, Dyspnoea, Rash
Clinical narrative: Difficulty breathing that lasted for a week; Dizziness; Rash; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (Difficulty breathing that lasted for a week), DIZZINESS (Dizziness) and RASH (Rash) in a 76-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 23-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Feb-2021, the patient experienced DYSPNOEA (Difficulty breathing that lasted for a week), DIZZINESS (Dizziness) and RASH (Rash). At the time of the report, DYSPNOEA (Difficulty breathing that lasted for a week), DIZZINESS (Dizziness) and RASH (Rash) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported.  No treatment information was provided.
Age: 94.0
Sex: F
Vaccine: COVID19
Symptoms: Hypokinesia
Clinical narrative: Could not lift her arm for a few days after the vaccine; This spontaneous case was reported by a consumer and describes the occurrence of HYPOKINESIA (Could not lift her arm for a few days after the vaccine) in a 94-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced HYPOKINESIA (Could not lift her arm for a few days after the vaccine). At the time of the report, HYPOKINESIA (Could not lift her arm for a few days after the vaccine) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported.  Patient received vaccine on a Thursday and patient recovered from reported event on a Saturday.  Treatment information was not provided.
Sex: F
Vaccine: COVID19
Symptoms: Bedridden, Malaise, Pyrexia, Vomiting
Clinical narrative: Bedbound; Sick; Vomiting; Fever; This spontaneous case was reported by a consumer and describes the occurrence of BEDRIDDEN (Bedbound), MALAISE (Sick), VOMITING (Vomiting) and PYREXIA (Fever) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced BEDRIDDEN (Bedbound), MALAISE (Sick), VOMITING (Vomiting) and PYREXIA (Fever). At the time of the report, BEDRIDDEN (Bedbound), MALAISE (Sick), VOMITING (Vomiting) and PYREXIA (Fever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications reported.  Treatment medications was not provided by the reporter
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Paraesthesia oral
Clinical narrative: Lips tingling; This spontaneous case was reported by a pharmacist and describes the occurrence of PARAESTHESIA ORAL (Lips tingling) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 023M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 17-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Feb-2021, the patient experienced PARAESTHESIA ORAL (Lips tingling). On 17-Feb-2021, PARAESTHESIA ORAL (Lips tingling) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported.  No treatment was provided.
Age: 92.0
Sex: M
Vaccine: COVID19
Symptoms: Balance disorder, Dizziness, Feeling abnormal, Gait disturbance, Sinus headache
Clinical narrative: sinus headache above eyebrows; light headedness; not dizzy but balance has been off; have to be careful and walk slowly; it's like a swimming effect; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (light headedness), BALANCE DISORDER (not dizzy but balance has been off), GAIT DISTURBANCE (have to be careful and walk slowly), FEELING ABNORMAL (it's like a swimming effect) and SINUS HEADACHE (sinus headache above eyebrows) in a 92-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 023M20A) for COVID-19 vaccination.     Concurrent medical conditions included Sinus headache and Neuropathy (Neuropathy in both Legs). Concomitant products included LEVETIRACETAM (KEPPRA), WARFARIN SODIUM (COUMADIN), SOLIFENACIN SUCCINATE (VESICARE), ATORVASTATIN CALCIUM (LIPITOR), ACETYLSALICYLIC ACID (BABY ASPIRIN), ASCORBIC ACID, BETACAROTENE, CUPRIC OXIDE, TOCOPHERYL ACETATE, ZINC OXIDE (PRESERVISION), TIMOLOL MALEATE, LATANOPROST and MULTIVITAMIN [VITAMINS NOS] for an unknown indication.    On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Feb-2021, the patient experienced DIZZINESS (light headedness), BALANCE DISORDER (not dizzy but balance has been off), GAIT DISTURBANCE (have to be careful and walk slowly) and FEELING ABNORMAL (it's like a swimming effect). On 03-Mar-2021, the patient experienced SINUS HEADACHE (sinus headache above eyebrows). The patient was treated with PARACETAMOL (TYLENOL) for Adverse reaction, at a dose of 1 dosage form. At the time of the report, DIZZINESS (light headedness), BALANCE DISORDER (not dizzy but balance has been off), GAIT DISTURBANCE (have to be careful and walk slowly), FEELING ABNORMAL (it's like a swimming effect) and SINUS HEADACHE (sinus headache above eyebrows) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Reporter did not allow further contact   Most recent FOLLOW-UP information incorporated above includes: On 20-Jul-2021: Follow-up information received on 21 Jul 2021 contains significant information. event outcome of all events updated to recovered
Age: 28.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Dizziness, Headache, Nausea
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Dizziness), HEADACHE (Headache), NAUSEA (Nausea) and CHILLS (Chills) in a 28-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011J20A) for COVID-19 vaccination.     No Medical History information was reported.    On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Feb-2021, the patient experienced DIZZINESS (Dizziness), HEADACHE (Headache), NAUSEA (Nausea) and CHILLS (Chills). At the time of the report, DIZZINESS (Dizziness), HEADACHE (Headache), NAUSEA (Nausea) and CHILLS (Chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication details were provided. No treatment medication details were provided.
Sex: M
Vaccine: COVID19
Symptoms: Chills, Pyrexia
Clinical narrative: high fever; chills; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (high fever) and CHILLS (chills) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No relevant medical history reported).    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Mar-2021, the patient experienced PYREXIA (high fever) and CHILLS (chills). At the time of the report, PYREXIA (high fever) and CHILLS (chills) outcome was unknown.            Concomitant medications were not reported.   No treatment details were reported.
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Headache, Hypersensitivity, Irritable bowel syndrome
Clinical narrative: irritable bowel syndrome; allergies; chills; fatigue; nausea; tingling lips; headache; sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PARAESTHESIA ORAL (tingling lips), HEADACHE (headache), PAIN IN EXTREMITY (sore arm), CHILLS (chills) and FATIGUE (fatigue) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event since an unknown date. Concomitant products included DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL N) for an unknown indication.    On 20-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Feb-2021, the patient experienced PARAESTHESIA ORAL (tingling lips), HEADACHE (headache) and PAIN IN EXTREMITY (sore arm). On 26-Feb-2021, the patient experienced CHILLS (chills), FATIGUE (fatigue) and NAUSEA (nausea). On an unknown date, the patient experienced IRRITABLE BOWEL SYNDROME (irritable bowel syndrome) and HYPERSENSITIVITY (allergies). At the time of the report, PARAESTHESIA ORAL (tingling lips), HEADACHE (headache), PAIN IN EXTREMITY (sore arm), CHILLS (chills), FATIGUE (fatigue) and NAUSEA (nausea) had not resolved and IRRITABLE BOWEL SYNDROME (irritable bowel syndrome) and HYPERSENSITIVITY (allergies) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Pain in extremity, Paraesthesia oral
Clinical narrative: irritable bowel syndrome; allergies; chills; fatigue; nausea; tingling lips; headache; sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PARAESTHESIA ORAL (tingling lips), HEADACHE (headache), PAIN IN EXTREMITY (sore arm), CHILLS (chills) and FATIGUE (fatigue) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event since an unknown date. Concomitant products included DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL N) for an unknown indication.    On 20-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Feb-2021, the patient experienced PARAESTHESIA ORAL (tingling lips), HEADACHE (headache) and PAIN IN EXTREMITY (sore arm). On 26-Feb-2021, the patient experienced CHILLS (chills), FATIGUE (fatigue) and NAUSEA (nausea). On an unknown date, the patient experienced IRRITABLE BOWEL SYNDROME (irritable bowel syndrome) and HYPERSENSITIVITY (allergies). At the time of the report, PARAESTHESIA ORAL (tingling lips), HEADACHE (headache), PAIN IN EXTREMITY (sore arm), CHILLS (chills), FATIGUE (fatigue) and NAUSEA (nausea) had not resolved and IRRITABLE BOWEL SYNDROME (irritable bowel syndrome) and HYPERSENSITIVITY (allergies) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Feeling abnormal, Injection site pruritus, Vaccination site swelling
Clinical narrative: Feeling strange; Itching at injection; Swollen at injection site; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (Feeling strange), INJECTION SITE PRURITUS (Itching at injection) and VACCINATION SITE SWELLING (Swollen at injection site) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038k20a) for COVID-19 vaccination.     Concurrent medical conditions included Blood pressure abnormal. Concomitant products included METFORMIN for an unknown indication.    On 22-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced FEELING ABNORMAL (Feeling strange), INJECTION SITE PRURITUS (Itching at injection) and VACCINATION SITE SWELLING (Swollen at injection site). At the time of the report, FEELING ABNORMAL (Feeling strange), INJECTION SITE PRURITUS (Itching at injection) and VACCINATION SITE SWELLING (Swollen at injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient's concomitant medications also included unspecified supplements and medicine for blood pressure.  Treatment medications was not provided by the reporter
Age: 89.0
Sex: M
Vaccine: COVID19
Symptoms: Erythema, Pain in extremity, Rash
Clinical narrative: Redness; Sore arm; Rash on chest and arm; This spontaneous case was reported by a consumer and describes the occurrence of ERYTHEMA (Redness), PAIN IN EXTREMITY (Sore arm) and RASH (Rash on chest and arm) in an 89-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 051L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Feb-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-Feb-2021, the patient experienced ERYTHEMA (Redness) and PAIN IN EXTREMITY (Sore arm). In February 2021, the patient experienced RASH (Rash on chest and arm). At the time of the report, ERYTHEMA (Redness) and PAIN IN EXTREMITY (Sore arm) had resolved and RASH (Rash on chest and arm) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications reported.  Treatment medications was not provided by the reporter
Age: 22.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Chest pain, Pain in extremity, Pyrexia
Clinical narrative: right arm hurt; right shoulder hurt; chest pain; fever all night of 101.8; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (fever all night of 101.8), PAIN IN EXTREMITY (right arm hurt), ARTHRALGIA (right shoulder hurt) and CHEST PAIN (chest pain) in a 22-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event on 03-Mar-2021.    On 01-Mar-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On 01-Mar-2021, the patient experienced PYREXIA (fever all night of 101.8). On 02-Mar-2021, the patient experienced PAIN IN EXTREMITY (right arm hurt), ARTHRALGIA (right shoulder hurt) and CHEST PAIN (chest pain).        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.
Age: 21.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Lacrimation increased, Mobility decreased, Vaccination site pain, Vaccination site swelling
Clinical narrative: eyes have been watering; swelling; Pain; fatigued; cant even drive with left had; This spontaneous case was reported by a consumer and describes the occurrence of LACRIMATION INCREASED (eyes have been watering), VACCINATION SITE SWELLING (swelling), VACCINATION SITE PAIN (Pain), FATIGUE (fatigued) and MOBILITY DECREASED (cant even drive with left had) in a 21-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 022M20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event. Concomitant products included ETHINYLESTRADIOL, NORGESTIMATE (TRI-SPRINTEC) for an unknown indication.   On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form.   On 11-Feb-2021, the patient experienced LACRIMATION INCREASED (eyes have been watering), VACCINATION SITE SWELLING (swelling), VACCINATION SITE PAIN (Pain), FATIGUE (fatigued) and MOBILITY DECREASED (cant even drive with left had).   At the time of the report, LACRIMATION INCREASED (eyes have been watering), VACCINATION SITE SWELLING (swelling), VACCINATION SITE PAIN (Pain), FATIGUE (fatigued) and MOBILITY DECREASED (cant even drive with left had) outcome was unknown.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   No treatment information was provided.
Sex: M
Vaccine: COVID19
Symptoms: Vomiting
Clinical narrative: throw up again; throw up; A spontaneous report was received from a consumer concerning a 76-years-old female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events throw up, throw up again.  The patient's medical history was not provided. No relevant concomitant medications were reported.  On 17 Feb 2021, prior to the onset of the events the patient received first of two planned doses of mRNA-1273 (lot/batch: 039K20A) via unknown route for prophylaxis of COVID-19 infection.  On 19 Feb 2021, the patient experienced the event(s) throw up. On 2 Mar 2021, the patient experienced the event(s) throw up again.  No treatment information was provided.  Action taken with mRNA-1273 in response to the events was not reported.   The outcome of event(s), throw up, throw up again was unknown.